Pheton Holdings Debt to Equity Ratio 2023-2024 | PTHL
Current and historical debt to equity ratio values for Pheton Holdings (PTHL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pheton Holdings debt/equity for the three months ending December 31, 2024 was 0.00.
| Pheton Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $0.00B | $0.01B | 0.09 |
| 2024-06-30 | $0.00B | $0.00B | 83.06 |
| 2023-12-31 | $0.00B | $0.00B | 4.28 |
| 2022-12-31 | $0.00B | $0.00B | 1.52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.373B | 30.92 |
| HCA Healthcare (HCA) | United States | $107.724B | 17.83 |
| CVS Health (CVS) | United States | $101.935B | 11.72 |
| Elevance Health (ELV) | United States | $82.857B | 12.15 |
| Cencora (COR) | United States | $65.122B | 20.99 |
| Natera (NTRA) | United States | $32.410B | 0.00 |
| DiDi Global (DIDIY) | China | $24.285B | 22.43 |
| Labcorp Holdings (LH) | United States | $20.875B | 15.92 |
| Medpace Holdings (MEDP) | United States | $16.760B | 41.61 |
| BioMerieux (BMXMF) | France | $15.630B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.207B | 0.00 |
| Solventum (SOLV) | United States | $14.941B | 14.50 |
| Viatris (VTRS) | United States | $14.697B | 5.48 |
| ICON (ICLR) | Ireland | $14.648B | 14.53 |
| Revvity (RVTY) | United States | $11.840B | 21.80 |
| CochLear (CHEOY) | Australia | $11.530B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.872B | 20.94 |
| Avantor (AVTR) | United States | $8.461B | 12.93 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.044B | 0.00 |
| HealthEquity (HQY) | United States | $8.044B | 30.08 |
| Sonic Healthcare (SKHHY) | Australia | $7.443B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.769B | 40.35 |
| PACS (PACS) | United States | $6.464B | 39.31 |
| Bausch + Lomb (BLCO) | Canada | $6.096B | 40.02 |
| Sotera Health (SHC) | United States | $5.455B | 26.30 |
| Alignment Healthcare (ALHC) | United States | $4.158B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.913B | 68.72 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| Concentras Parent (CON) | United States | $2.551B | 15.92 |
| Progyny (PGNY) | United States | $2.327B | 45.75 |
| Organon (OGN) | United States | $2.093B | 2.21 |
| Surgery Partners (SGRY) | United States | $2.085B | 26.87 |
| Establishment Labs Holdings (ESTA) | United States | $1.986B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.919B | 11.46 |
| Teladoc Health (TDOC) | United States | $1.324B | 0.00 |
| Nutex Health (NUTX) | United States | $1.317B | 10.07 |
| Ardent Health (ARDT) | United States | $1.270B | 4.14 |
| GoodRx Holdings (GDRX) | United States | $0.950B | 15.56 |
| Omada Health (OMDA) | United States | $0.892B | 0.00 |
| CareDx (CDNA) | United States | $0.881B | 14.40 |
| Embecta (EMBC) | United States | $0.756B | 4.30 |
| InnovAge Holding (INNV) | United States | $0.719B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.693B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| CryoPort (CYRX) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.505B | 22.66 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.491B | 0.00 |
| SBC Medicals (SBC) | United States | $0.455B | 8.38 |
| Agilon Health (AGL) | United States | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.411B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.361B | 5.81 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| KindlyMD (NAKA) | United States | $0.188B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.142B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |